This study aims to evaluate the effectiveness and acceptability of dual-focus soft contact lenses in controlling rapid myopia progression in adults through a randomized controlled trial. By applying myopia control measures to the adult population, we hope to provide scientific evidence for the effective control of adult myopia progression and offer insights into the understanding of myopia progression during early adulthood.
Age 18-25 years;
Myopia progression <= -0.50D in either eye in the past year (evaluated by -manifest refraction);
The subject eye: cycloplegic spherical equivalent ranges from -2.00D to -6.0D and cylinder power doesn't exceed -1.50D;
The subject eye's best corrected visual acuity <= logMAR 0.1;
Current use of MC interventions or prior use of MC interventions within the past 6 months;
Disease or anatomical factors that affect the wearing of contact lenses;
History of myopia correction surgery;
Suffering from ocular or systemic diseases that may be related to myopia, such as Marfan syndrome, retinopathy of prematurity, diabetes, etc.;
Parallel
MiSight® 1 day soft contact lenses
DeviceDual-focus contact lenses, daily disposable, material: omafilcon A, water content: 60%.
Proclear® 1 day soft contact lenses
DeviceSingle-vision contact lenses, daily disposable, material: omafilcon A, water content: 60%.
Change in cycloplegic spherical equivalent after 2 years
The difference in the change of cycloplegic spherical equivalent between the intervention group and the control group.
Change in axial length after 2 years
The difference in the change of axial length between the intervention group and the control group.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
